Synpromics is developing a strategic portfolio of valuable synthetic promoters for specific application across its target markets, such as cell & gene therapy, bio-manufacturing, and industrial & agricultural biotechnologies. Synthetic promoters are DNA sequences that do not exist in nature and which are designed to regulate the activity of genes, controlling a gene’s ability to produce its own uniquely encoded protein. Currently, within the biotech industry, naturally occurring promoters are used to drive protein production.